BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 16848199)

  • 1. [Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma].
    Sesar A; Petric I; Sesar I; Lacmnovic-Loncar V; Jurisić D; Tomić Z; Mandić Z
    Acta Med Croatica; 2006; 60(2):109-12. PubMed ID: 16848199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neodymium:yttrium-aluminum-garnet capsulotomy and intraocular pressure in pseudophakic patients with glaucoma.
    Barnes EA; Murdoch IE; Subramaniam S; Cahill A; Kehoe B; Behrend M
    Ophthalmology; 2004 Jul; 111(7):1393-7. PubMed ID: 15234143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
    Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
    Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C; Jörg KM; Trinkmann R
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal detachment in pseudophakic eyes with and without Nd:YAG laser posterior capsulotomy.
    Ranta P; Kivelä T
    Ophthalmology; 1998 Nov; 105(11):2127-33. PubMed ID: 9818617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent elevation in intraocular pressure after Nd:YAG laser treatment.
    Demer JL; Koch DD; Smith JA; Knolle GE
    Ophthalmic Surg; 1986 Aug; 17(8):465-6. PubMed ID: 3748536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.
    Cullom RD; Schwartz LW
    Ophthalmic Surg; 1993 Sep; 24(9):623-6. PubMed ID: 7901828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy.
    Pollack IP; Brown RH; Crandall AS; Robin AL; Stewart RH; White GL
    Trans Am Ophthalmol Soc; 1988; 86():461-72. PubMed ID: 2979050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term elevation of intraocular pressure after neodymium: YAG laser posterior capsulotomy.
    Jahn CE; Emke M
    Ophthalmologica; 1996; 210(2):85-9. PubMed ID: 9148259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior capsulotomy using a neodymium YAG laser.
    Woodward PM
    Ann Ophthalmol; 1984 Jun; 16(6):534, 536-9. PubMed ID: 6742694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intraocular lens fixation on acute intraocular pressure rise after neodymium-YAG laser capsulotomy.
    Anand N; Tole DM; Morrell AJ
    Eye (Lond); 1996; 10 ( Pt 4)():509-13. PubMed ID: 8944108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of apraclonidine to prevent delayed IOP elevation after Nd:YAG laser posterior capsulotomy.
    Nesher R; Kolker AE
    Trans Am Ophthalmol Soc; 1990; 88():229-32; discussion 233-6. PubMed ID: 1982748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAG curios #1: repeat Nd:YAG laser posterior capsulotomy.
    Jayaram H; Uppal G; Hugkulstone CE; Gibbens MV; Watt L
    Acta Ophthalmol Scand; 2005 Apr; 83(2):242-4. PubMed ID: 15799741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of Nd:YAG laser capsulotomy in posterior capsule opacification.
    Polak M; Zarnowski T; Zagórski Z
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):357-63. PubMed ID: 12898944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal breaks and detachment after neodymium: YAG laser posterior capsulotomy: five-year incidence in a prospective cohort.
    Ranta P; Tommila P; Kivelä T
    J Cataract Refract Surg; 2004 Jan; 30(1):58-66. PubMed ID: 14967269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pupillary block following Nd:YAG laser capsulotomy.
    Ruderman JM; Mitchell PG; Kraff M
    Ophthalmic Surg; 1983 May; 14(5):418-9. PubMed ID: 6877743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy.
    Kitazawa Y; Taniguchi T; Sugiyama K
    Ophthalmic Surg; 1989 Jan; 20(1):49-52. PubMed ID: 2648232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.